I-123 MIBG Radiopharmaceutical Supply

The contract pertains to the supply of iodine-123 metaiodobenzylguanidine (I-123 MIBG), a radiopharmaceutical used specifically for the imaging and diagnosis of neuroendocrine tumors. This subcontract is issued under the Department of Veterans Affairs through the 257-NETWORK Contract Office 17, with performance scheduled to take place in Amarillo, Texas, at the ZIP code 79106. The naics code 325412 indicates that the activity is classified under pharmaceutical and medicine manufacturing, emphasizing the specialized production and handling requirements of this radiopharmaceutical. The contract was posted on May 1, 2026, and is intended to support critical diagnostic capabilities within VA healthcare facilities, ensuring a reliable and consistent supply of I-123 MIBG for clinical use in nuclear medicine. The terms of the agreement will require adherence to strict regulatory, safety, and quality standards due to the radioactive nature of the product and its direct application in patient diagnostics.